Literature DB >> 19738268

The policy on paying for treating hospital-acquired conditions: CMS officials respond.

Barry Straube1, Jonathan D Blum.   

Abstract

Policies that decline payment in the event of hospital-acquired conditions have generated considerable public attention. Although the projected payment reductions are not large, small payment penalties have been effective in changing human behavior and ultimately in improving the hospital care experience for patients. Many state Medicaid programs and commercial payers have adopted similar policies. Medicare payment reductions for hospital-acquired conditions are only one component of several efforts to reduce their incidence. The Centers for Medicare and Medicaid Services (CMS) will refine these policies as appropriate. Other CMS strategies to reduce hospital-acquired conditions include public reporting, quality improvement initiatives, value-based purchasing, quality metrics and guidelines development, and national coverage decisions.

Entities:  

Mesh:

Year:  2009        PMID: 19738268     DOI: 10.1377/hlthaff.28.5.1494

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  5 in total

1.  Factors associated with 30-day readmission rates after percutaneous coronary intervention.

Authors:  Farhan J Khawaja; Nilay D Shah; Ryan J Lennon; Joshua P Slusser; Aziz A Alkatib; Charanjit S Rihal; Bernard J Gersh; Victor M Montori; David R Holmes; Malcolm R Bell; Jeptha P Curtis; Harlan M Krumholz; Henry H Ting
Journal:  Arch Intern Med       Date:  2011-11-28

2.  CMS reimbursement reform and the incidence of hospital-acquired pulmonary embolism or deep vein thrombosis.

Authors:  Risha Gidwani; Jay Bhattacharya
Journal:  J Gen Intern Med       Date:  2014-12-18       Impact factor: 5.128

3.  Trends in mortality, length of stay, and hospital charges associated with health care-associated infections, 2006-2012.

Authors:  Sherry Glied; Bevin Cohen; Jianfang Liu; Matthew Neidell; Elaine Larson
Journal:  Am J Infect Control       Date:  2016-05-17       Impact factor: 2.918

4.  Factors associated with 30-day readmission and long-term efficacy of enteral stent placement for malignancy.

Authors:  Udayakumar Navaneethan; Sudhir Duvuru; Ramprasad Jegadeesan; Preethi G K Venkatesh; Norma G Gutierrez; Jeffrey Hammel; Ravi P Kiran; Madhusudhan R Sanaka
Journal:  Surg Endosc       Date:  2014-04       Impact factor: 4.584

5.  Including catheter-associated urinary tract infections in the 2008 CMS payment policy: a qualitative analysis.

Authors:  Jennifer A Palmer; Grace M Lee; M Maya Dutta-Linn; Peter Wroe; Christine W Hartmann
Journal:  Urol Nurs       Date:  2013 Jan-Feb
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.